QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.40 (-3.90%)
BABA   78.61 (-2.91%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.41%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.54%)
AMC   4.63 (-0.22%)
PFE   37.02 (-1.54%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.40 (-3.90%)
BABA   78.61 (-2.91%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.41%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.54%)
AMC   4.63 (-0.22%)
PFE   37.02 (-1.54%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.40 (-3.90%)
BABA   78.61 (-2.91%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.41%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.54%)
AMC   4.63 (-0.22%)
PFE   37.02 (-1.54%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)
QQQ   349.98 (+0.45%)
AAPL   177.30 (+1.07%)
MSFT   331.21 (-0.50%)
META   262.52 (+0.18%)
GOOGL   123.67 (-0.75%)
AMZN   121.66 (+1.29%)
TSLA   201.16 (+4.14%)
NVDA   401.11 (+2.99%)
NIO   7.40 (-3.90%)
BABA   78.61 (-2.91%)
AMD   125.27 (-1.39%)
T   15.64 (+0.90%)
F   12.59 (+4.14%)
MU   71.69 (-3.03%)
CGC   0.85 (-3.41%)
GE   102.40 (-0.33%)
DIS   87.82 (-0.54%)
AMC   4.63 (-0.22%)
PFE   37.02 (-1.54%)
PYPL   62.05 (+3.04%)
NFLX   392.98 (+3.72%)

Pulse Biosciences (PLSE) Stock Forecast, Price & News

$5.97
-0.15 (-2.45%)
(As of 05/30/2023 ET)
Compare
Today's Range
$5.86
$6.27
50-Day Range
$2.48
$8.64
52-Week Range
$1.18
$9.69
Volume
70,074 shs
Average Volume
88,775 shs
Market Capitalization
$224.71 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Pulse Biosciences MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
28.14% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.60
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$65.25 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.83 out of 5 stars

Medical Sector

834th out of 1,009 stocks

Surgical & Medical Instruments Industry

84th out of 104 stocks


PLSE stock logo

About Pulse Biosciences (NASDAQ:PLSE) Stock

Pulse Biosciences, Inc. operates as an immuno-oncology company developing a proprietary oncolytic electroceutical therapy based on its Nano Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Hayward, CA.

Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Stock News Headlines

The “Amazon Secret Royalty Program” Can Help Anyone Retire Like Royalty
A unique type of investment could help you make more money than you will need for the rest of your life. It’s what we call the “Amazon secret royalty program.” It’s an income stream that allows you to collect $1,000s… $10,000s… or more every year! Learn how to collect your first payout before June 13th.
Q1 2023 Pulse Biosciences Inc Earnings Call
Recap: Pulse Biosciences Q1 Earnings
Introducing MarketBeat All Access
Get real-time financial news and market data with MarketBeat All Access. Monitor your portfolio and the markets. Access our top stock picks, unbeatable research tools, best-in-class stock screeners, and proprietary research reports.
Pulse Biosciences (PLSE) to Release Earnings on Thursday
8-K: Pulse Biosciences, Inc.
Pulse Biosciences (NASDAQ:PLSE) Posts Earnings Results
See More Headlines
Receive PLSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pulse Biosciences and its competitors with MarketBeat's FREE daily newsletter.

PLSE Company Calendar

Last Earnings
5/11/2023
Today
5/30/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:PLSE
Fax
N/A
Employees
142
Year Founded
N/A

Profitability

Net Income
$-58,510,000.00
Pretax Margin
-19,934.77%

Debt

Sales & Book Value

Annual Sales
$700,000.00
Book Value
($0.06) per share

Miscellaneous

Free Float
16,939,000
Market Cap
$224.71 million
Optionable
Optionable
Beta
1.13

Key Executives

  • Kevin P. Danahy
    President, Chief Executive & Financial Officer
  • Edison Manuel
    Vice President-Operations
  • Darrin R. Uecker
    Director & Chief Technology Officer
  • David Danitz
    Senior Vice President-Engineering
  • Dunnington Gansevoort
    Chief Medical Officer













PLSE Stock - Frequently Asked Questions

Should I buy or sell Pulse Biosciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Pulse Biosciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PLSE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PLSE, but not buy additional shares or sell existing shares.
View PLSE analyst ratings
or view top-rated stocks.

How have PLSE shares performed in 2023?

Pulse Biosciences' stock was trading at $2.77 at the beginning of the year. Since then, PLSE shares have increased by 115.5% and is now trading at $5.97.
View the best growth stocks for 2023 here
.

When is Pulse Biosciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our PLSE earnings forecast
.

How were Pulse Biosciences' earnings last quarter?

Pulse Biosciences, Inc. (NASDAQ:PLSE) released its quarterly earnings data on Thursday, May, 11th. The company reported ($0.25) earnings per share for the quarter.

What is Darrin R. Uecker's approval rating as Pulse Biosciences' CEO?

2 employees have rated Pulse Biosciences Chief Executive Officer Darrin R. Uecker on Glassdoor.com. Darrin R. Uecker has an approval rating of 100% among the company's employees. This puts Darrin R. Uecker in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Pulse Biosciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pulse Biosciences investors own include Advanced Micro Devices (AMD), AbbVie (ABBV), Bausch Health Companies (BHC), Wayfair (W), Achaogen (AKAO), NVIDIA (NVDA), Portola Pharmaceuticals (PTLA), Enphase Energy (ENPH) and Novavax (NVAX).

When did Pulse Biosciences IPO?

(PLSE) raised $20 million in an IPO on Wednesday, May 18th 2016. The company issued 5,000,000 shares at a price of $4.00 per share. MDB Capital Group and Feltl and Company served as the underwriters for the IPO.

What is Pulse Biosciences' stock symbol?

Pulse Biosciences trades on the NASDAQ under the ticker symbol "PLSE."

Who are Pulse Biosciences' major shareholders?

Pulse Biosciences' stock is owned by many different institutional and retail investors. Top institutional investors include Bank of America Corp DE (2.06%), Griffin Asset Management Inc. (0.45%), Geode Capital Management LLC (0.38%), Westside Investment Management Inc. (0.30%), Spotlight Asset Group Inc. (0.18%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Kevin Patrick Danahy, Maky Zanganeh, Mitchell E Levinson and Robert W Duggan.
View institutional ownership trends
.

How do I buy shares of Pulse Biosciences?

Shares of PLSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Pulse Biosciences' stock price today?

One share of PLSE stock can currently be purchased for approximately $5.97.

How much money does Pulse Biosciences make?

Pulse Biosciences (NASDAQ:PLSE) has a market capitalization of $224.71 million and generates $700,000.00 in revenue each year. The company earns $-58,510,000.00 in net income (profit) each year or ($1.44) on an earnings per share basis.

How many employees does Pulse Biosciences have?

The company employs 142 workers across the globe.

How can I contact Pulse Biosciences?

Pulse Biosciences' mailing address is 3957 POINT EDEN WAY, HAYWARD CA, 94545. The official website for the company is www.pulsebiosciences.com. The company can be reached via phone at (510) 906-4600 or via email at ir@pulsebiosciences.com.

This page (NASDAQ:PLSE) was last updated on 5/30/2023 by MarketBeat.com Staff

My Account -